Mark Hazeltine - Net Worth and Insider Trading
Mark Hazeltine Net Worth
The estimated net worth of Mark Hazeltine is at least $270,351 dollars as of 2024-10-18. Mark Hazeltine is the Chief Business Officer of Exagen Inc and owns about 93,872 shares of Exagen Inc (XGN) stock worth over $270,351. Details can be seen in Mark Hazeltine's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Hazeltine has not made any transactions after 2023-02-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Hazeltine
Mark Hazeltine Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Hazeltine owns 1 companies in total, including Exagen Inc (XGN) .
Click here to see the complete history of Mark Hazeltine’s form 4 insider trades.
Insider Ownership Summary of Mark Hazeltine
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
XGN | Exagen Inc | 2023-02-08 | Chief Operating Officer |
Mark Hazeltine Latest Holdings Summary
Mark Hazeltine currently owns a total of 1 stock. Mark Hazeltine owns 93,872 shares of Exagen Inc (XGN) as of February 8, 2023, with a value of $270,351.
Latest Holdings of Mark Hazeltine
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
XGN | Exagen Inc | 2023-02-08 | 93,872 | 2.88 | 270,351 |
Holding Weightings of Mark Hazeltine
Mark Hazeltine Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Hazeltine has made a total of 1 transactions in Exagen Inc (XGN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Exagen Inc is the sale of 5,821 shares on February 8, 2023, which brought Mark Hazeltine around $15,659.
Insider Trading History of Mark Hazeltine
- 1
Mark Hazeltine Trading Performance
Mark Hazeltine Ownership Network
Mark Hazeltine Owned Company Details
What does Exagen Inc do?
Who are the key executives at Exagen Inc?
Mark Hazeltine is the Chief Operating Officer of Exagen Inc. Other key executives at Exagen Inc include director & President and CEO John Aballi , Chief Financial Officer Kamal Adawi , and 10 percent owner Tullis Growth Fund Ii, L.p. .
Exagen Inc (XGN) Insider Trades Summary
Over the past 18 months, Mark Hazeltine made no insider transaction in Exagen Inc (XGN). Other recent insider transactions involving Exagen Inc (XGN) include a net sale of 19,522 shares made by Kamal Adawi , a net purchase of 6,582 shares made by John Aballi , and a net purchase of 167 shares made by Tullis Growth Fund Ii, L.p. .
In summary, during the past 3 months, insiders sold 0 shares of Exagen Inc (XGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 53,341 shares of Exagen Inc (XGN) were sold and 40,568 shares were bought by its insiders, resulting in a net sale of 12,773 shares.
Exagen Inc (XGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Exagen Inc Insider Transactions
Mark Hazeltine Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Hazeltine. You might contact Mark Hazeltine via mailing address: C/o Exagen Inc., 1261 Liberty Way, Suite C, Vista Ca 92081.